4
Changes in Ownership
CLOVER HEALTH INVESTMENTS, CORP. /DE Filed Acc 0001971702-26-000017
CEO, Counterpart Health sold 300,000 shares at $4.72 ($1,416,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wai Conrad CEO, Counterpart Health | 2026-09-15 | Sale 10b5-1 | −300,000 | $4.72 | $1,416,000 | 1,170,056 | I: show line 1 in the form |
| Open-market sales · 300,000 sh · avg $4.72 · $1,416,000 | |||||||
Loading xslF345X06/wk-form4_1789590444.xml…